Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma

• Hauptverfasser: Wei Wu (Verfasst von), Yong Dai (Verfasst von), Han Liu (Verfasst von), Ruoyu Cheng (Verfasst von), Qing Ni (Verfasst von), Tingjun Ye (Verfasst von), Wenguo Cui (Verfasst von)
• Format: Buch
• Veröffentlicht: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Osteosarcoma is among the most common malignant bone tumors in human skeletal system. The conventional treatment of osteosarcoma mainly consists of combining neoadjuvant chemotherapy with surgical approach. However, it is crucial to design an artificial implant that possesses excellent biomechanical...